This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Textor, S. C. Articles by McKusick, M. Search for Related Content PubMed Articles by Textor, S. C. Articles by McKusick, M. Related Collections Related Article

The Uncertain Value of Renal Artery Interventions

Where Are We Now?

Stephen C. Textor, MD^_*,_*, Lilach Lerman, MD, PhD^_*, Michael McKusick, MD

^_* Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota
Department of Interventional Radiology, Mayo Clinic, Rochester, Minnesota

^_* Reprint requests and correspondence: Dr. Stephen C. Textor, Mayo Clinic, Nephrology and Hypertension, W19, 200 First Street, SW, Rochester, Minnesota 55905 (Email: textor.stephen{at}mayo.edu).

Improved technology for detection of and endovascular procedures for renal artery stenosis due to atherosclerosis has been associated with increases in renal artery intervention. Hypertension with accelerated target organ injury, reduced kidney function, and episodic circulatory congestion in patients with renovascular disease predict reduced patient survival. Recent studies indicate that activation of pressor mechanisms depends upon hemodynamic gradients that are often overrated by visual estimates. Although activation of the renin-angiotensin system initiates renovascular hypertension, additional mechanisms perpetuate vascular remodeling and kidney injury that may not depend upon large vessel occlusion. Major advances in medical therapy have led to initiation of at least 4 major prospective trials comparing optimal medical therapy with or without stenting. Up to now, outcome data fail to support broad application of renal revascularization, including results from a recent large, prospective trial from the United Kingdom, despite small groups of patients that experience major clinical benefit. The ambiguity of these results partly reflect poor characterization of the severity of vascular lesions and competing risks within the population related to aging and pre-existing disease. Many patients currently undergoing renal artery interventions derive little net benefit and some are exposed to significant complications, including atheroembolic disease. Determining the appropriate role for renal artery interventions will depend on developing better methods for judging the role of large vessel occlusive disease regarding tissue oxygenation, activation of profibrotic pathways, and irreversible injury in the post-stenotic kidney.

Key Words: atherosclerosis • chronic kidney disease • hypertension • renal artery stenosis • renal artery stenting

Abbreviations and Acronyms   RAS = renal artery stenosis

Related Article

Renal Artery Revascularization: Is There a Rationale to Perform?

Debabrata Mukherjee
J. Am. Coll. Cardiol. Intv. 2009 2: 183-184. [Full Text] [PDF]

This article has been cited by other articles:

				D. Mukherjee Renal Artery Revascularization: Is There a Rationale to Perform? J. Am. Coll. Cardiol. Intv., March 1, 2009; 2(3): 183 - 184. [Full Text] [PDF]